National survey of physicians’ perspectives on pharmacogenetic testing in solid organ transplantation
- 6 August 2020
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (10) , e14037
Abstract
Introduction: Our objective was to evaluate physicians' perspectives on the clinical utility of pharmacogenetic (PGx) testing in kidney, liver, heart, and lung transplantation (KLHL‐Tx).Methods: A 36‐question web‐based survey was developed and administered to medical and surgical directors of US KLHL‐Tx centers.Results: There were 82 respondents (10% response rate). The majority were men (78%), non‐Hispanic whites (70%), medical directors (72%), and kidney transplant physicians (35%). Although 78% of respondents reported having some PGx education, most reported lack of confidence in their PGx knowledge and ability to apply a PGx test. Participants reported mixed views about the clinical utility of PGx testing—most agreed with the efficacy of PGx testing, but not the benefits relative to the risks or standard of care. While 55% reported that testing was available at their institution, only 38% ordered a PGx test in the past year, most commonly thiopurine‐S‐methyltransferase. Physician‐reported barriers to PGx implementation included uncertainty about the clinical value of PGx testing and patient financial burden.Conclusion: Together, our findings suggest prospective PGx research and pilot implementation programs are needed to elucidate the clinical utility and value of PGx in KLHL‐Tx. These initiatives should include educational efforts to inform the use of PGx testing.Keywords
Funding Information
- Pharmaceutical Research and Manufacturers of America Foundation
This publication has 53 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 UpdateClinical Pharmacology & Therapeutics, 2014
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patientsWorld Journal of Gastroenterology, 2013
- Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials?Personalized Medicine, 2012
- Facing the Nonresponse ChallengeThe Annals of the American Academy of Political and Social Science, 2012
- Primary care physicians' knowledge of and experience with pharmacogenetic testingClinical Genetics, 2012
- Organizational structure and processes in pediatric heart transplantation: A survey of practicesPediatric Transplantation, 2012
- Warfarin Genotyping Reduces Hospitalization RatesJACC, 2010
- The effect of transplant center volume on survival after heart transplantation: A multicenter studyThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Transplant Center Volume and Outcomes After Liver RetransplantationAmerican Journal of Transplantation, 2009